Filing Details

Accession Number:
0001062993-25-010245
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2025-05-23 16:14:42
Reporting Period:
2025-05-20
Filing Date:
2025-05-23
Accepted Time:
2025-05-23 16:14:42
Original Submission Date:
2025-05-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799011 Lucid Diagnostics Inc. LUCD Surgical & Medical Instruments & Apparatus (3841) 825488042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817012 Dennis Matheis 360 Madison Avenue, 25Th Floor
New York NY 10017
Yes No No No
Transaction Summary
Purchased: 350,000 shares Avg. Price: $1.31 Total Value: $457,606.58
Number of Shares After Transactions: 565,443 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-20 187,098 $1.30 402,541 No 4 P Direct
Common Stock Acquisiton 2025-05-21 129,684 $1.32 532,225 No 4 P Direct
Common Stock Acquisiton 2025-05-22 33,218 $1.32 565,443 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4.
  2. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.315 to $1.32, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.305 to $1.32, inclusive.
  4. Includes 52,718 shares of Lucid common stock distributed on a pro rata basis to the reporting person by a limited partnership of which the reporting person is a limited partner.